Literature DB >> 18372091

[Principles of oncoplastic surgery in breast surgery].

Isabelle Cothier-Savey1, Françoise Rimareix.   

Abstract

After a conservative treatment for breast cancer, 75% of patients end up with a good aesthetic result, i.e. little or no residual asymmetry and minor postradiotherapy after-effects. In 20 to 25% of cases, the conservative treatment leaves lasting after-effects associated with surgery and radiotherapy. Such aesthetic after-effects are difficult to treat and they require additional plastic surgery in 5 to 10% of cases. Oncoplastic surgery, which combines large lumpectomy and remodeling procedure involving different plastic surgery methods, improves these cosmetic results after a partial mastectomy and widens the scope for conservative treatment. Today, these techniques are well codified. They range from simple reshaping to more sophisticated techniques involving a concomitant controlateral-breast-symmetrisation procedure. These surgical options must be elaborated in detail with the patient and depend on the patient, the type of the tumor, its position, the ratio between the volume of the tumor and that of the breast and the overall care given by a multispecialist team. Plastic surgery is now an integral part of the treatment of breast cancer, hence the use of the word: oncoplastic surgery.

Entities:  

Mesh:

Year:  2008        PMID: 18372091     DOI: 10.1016/j.anplas.2007.11.004

Source DB:  PubMed          Journal:  Ann Chir Plast Esthet        ISSN: 0294-1260            Impact factor:   0.660


  2 in total

1.  [Oncoplastie with breast conservation in breast cancer treatment: about 16 cases].

Authors:  Wail Bouzoubaa; Meryam Laadioui; Sofia Jayi; Fatime Zahra Fdili Alaoui; Hakima Bouguern; Hikmat Chaara; Moulay Abdelilah Melhouf
Journal:  Pan Afr Med J       Date:  2015-02-27

Review 2.  From radical mastectomy to breast-conserving therapy and oncoplastic breast surgery: a narrative review comparing oncological result, cosmetic outcome, quality of life, and health economy.

Authors:  Ahmad Kaviani; Nassim Sodagari; Sara Sheikhbahaei; Vahid Eslami; Nima Hafezi-Nejad; Amin Safavi; Maryam Noparast; Alfred Fitoussi
Journal:  ISRN Oncol       Date:  2013-09-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.